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Abstract
Objectives The Jordanian ‘Melissa’, (Aloysia citrodora) has been poorly studied
both pharmacologically and in the clinic. Essential oils (EO) derived from
leaves of A. citrodora were obtained by hydrodistillation, analysed by gas
chromatography-mass spectrometry (GC-MS) and were investigated for a range
of neurobiological and pharmacological properties, as a basis for potential future
use in drug discovery.
Methods A selection of central nervous system (CNS) receptor-binding profiles
was carried out. Antioxidant activity and ferrous iron-chelating assays were
adopted, and the neuroprotective properties of A. citrodora EO assessed using
hydrogen peroxide-induced and β-amyloid-induced neurotoxicity with the CAD
(Cath.-a-differentiated) neuroblastoma cell line.
Key findings The major chemical components detected in the A. citrodora
EOs, derived from dried and fresh leaves, included limonene, geranial, neral,
1, 8-cineole, curcumene, spathulenol and caryophyllene oxide, respectively.
A. citrodora leaf EO inhibited [3H] nicotine binding to well washed rat
forebrain membranes, and increased iron-chelation in vitro. A. citrodora EO
displays effective antioxidant, radical-scavenging activities and significant
protective properties vs both hydrogen peroxide- and β-amyloid-induced
neurotoxicity.
Conclusions A. citrodora EO displays a range of pharmacological properties
worthy of further investigation to isolate the compounds responsible for the
observed neuroactivities, to further analyse their mode of action and determine
their clinical potential in neurodegenerative diseases.
Introduction
Alzheimer’s disease (AD) is an age-related neuro-
degenerative disorder with characteristic clinical and patho-
logical features associated with loss of neurons in certain
brain areas, including cholinergic and glutamatergic
systems, leading to impairment of memory, pyscho-
behavioural disturbances and deficits in activities of daily
living, which eventually leads to death.[1–3] In 2010, approxi-
mately 35 million people worldwide were suffering from
AD, and this number is believed to increase to 66 million
by 2030.[2] To date, limited therapeutics are available,
which target the associated neuronal systems, namely
acetylcholinesterase inhibitors and N-methyl-D-aspartate
(NMDA) glutamate channel blockers.[4]
The interest in medicinal plant research and the aroma-
therapeutic effects of essential oils (EOs) in humans has
increased in recent years, especially for the treatment of
neuropathologies with profound social impact such as AD.
Oxidative stress plays a central role in the initiation and
progression of AD. The brain is particularly vulnerable to
oxidative damage because of its elevated oxygen utilisation
rate; high content of polyunsaturated lipids, which are sus-
ceptible to lipid peroxidation; accumulation of transition
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metals, which are capable of catalysing the formation of
reactive oxygen species (ROS) and relative paucity of cellu-
lar antioxidants.[5–7] Intracellular and extracellular amyloid
beta-protein (Aβ) accumulation and deposition are major
features of AD.[4] This neurotoxic protein inhibits the
electron transport chain in mitochondria, decreases the
respiratory rate, induces the release of ROS and may also
cause neurotoxicity through the direct production of ROS
via its interaction with transition metals and lipid mem-
branes.[7] To combat the cytotoxicity of ROS, cells are
endowed with a variety of antioxidant defence mechanisms,
including respective protective enzymes, namely catalase,
superoxide dismutase, glutathione and glutathione
peroxidase, as well as free-radical scavenger, such as ascor-
bate and vitamin E.[4,6] Natural antioxidants derived from a
multitude of plants display cytoprotective properties
in vitro and have a long history of use for human health
benefits.[8]
Several plant species are used in medical herbalism for
their effects on anxiety, restlessness, excitability and depres-
sion. These include lemon balm (Melissa officinalis),
lavender (Lavandula angustifolia), chamomile (Matricaria
chamomilla), bergamot (Monarda species), neroli (Citrus ×
aurnatium) and valerian (Valeriana officinalis).[9,10] Several
recent clinical trials have concurred with the value of
aromatherapy in people with dementia.[9,11] The safety of
these EO-based approaches has also been established in
clinical populations. Despite this, however, the central
mechanisms by which the EOs exert their effects are largely
unknown. Aloysia citrodora Palau Family (Verbenaceae),
also known as lemon verbena, is a perennial plant that
grows widely in South and Central America and in various
parts of the Middle East, including Jordan. The plant has
long been used in traditional medicine to prepare a tea for
its calming effects, sedative action and to counter
depression.[12–14] There is a large variety of phyto-
pharmaceutical preparations containing this plant or its
extracts used as an antipyretic, antispasmodic and diuretic
agents.[12,15] Furthermore, this plant is used in the food
industry to flavour different products.
Some plant material described as M. officinalis (known in
Arabic as ‘melissa’) was identified as A. citrodora (also
known locally as melissa); both species have similar tradi-
tional uses and produces a yellow to light green EO with
special aroma similar to that of lemon.[16] M. officinalis plant
has been of particular interest on account of its sedative,
cognitive-enhancing and anxiolytic-like effects, all relevant
pathophysiological actions seen in AD.[9,17–19] Very limited
data are available that explore the effects of A. citrodora oils
pertinent to AD, in comparison with M. officinalis. Detailed
pharmacological research is required to verify its potential
effectiveness. In this study, the EO derived from the leaves
of A. citrodora was validated, prepared, analysed and inves-
tigated for the first time for a range of neurological proper-
ties in cell-free systems, including radioligand binding,
radical-scavenging and iron-chelation properties. The
potential neuroprotective properties of this EO against oxi-
dative stress and Aβ-induced neurotoxicity were further
investigated using an in-vitro neuronal cell line system
to evaluate the potential of this EO as sources of
potent multitargeted therapeutics for treatment of neuro-
degenerative diseases.
Material and Methods
Plant material
Fresh leaves of A. citrodora were collected from plants
growing in the gardens of the Agricultural College of the
University of Jordan in spring 2011, when growth rates
were maximal. The plant was authenticated by Professor
Suleiman Al-Olimat from Department of Pharmaceutical
Sciences, Faculty of Pharmacy, The University of Jordan,
Amman (deposited herbarium voucher specimen refer-
ence: AC-V1). A portion of collected leaves was dried care-
fully under shade at room temperature and then
homogenised to fine powder and was stored in air within
tight bottles.
Essential oils preparation
Each 500 g of fresh and dried leaves of A. citrodora
was subjected to hydrodistillation with 1 l of water using
a Clevenger-type apparatus (JSOW, Haryana, India) for
3 h. The oils obtained for each specimen were dried with
anhydrous sodium sulphate and stored at 4°C in amber
glass vials until analysis. For all experiments, dilutions of
pure EOs stock were performed fresh on the day of the
assay.
Gas chromatography–mass spectrometry
The GC–MS analyses were performed using an
AutoSystem XL GC coupled to a TurboMass quadrupole
mass spectrometer (Perkin-Elmer, Shelton, Connecticut,
USA). Chromatography was performed on a
30 m × 0.25 mm ID × 0.25 μm DB-5 MS column (J & W
Scientific Inc., Rancho Cordova, CA, USA) using a tem-
perature programme of 40–300°C at a rate of 3°C/min.
The carrier gas was helium at a flow rate of 1 ml/min and
the injection volume was 1 μl (split 1:10) at 220°C, via an
autosampler. Detection was by MS, fitted with electrospray
ionisation source operated at 70 eV, with a source tem-
perature of 180°C; mass spectra were recorded in the range
m/z 38–600. The operating software was Turbomass,
version 4.1.1 (Perkin-Elmer). The A. citrodora oils were
diluted to 1.0% (v/v) with diethyl ether (GLC pesticide
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residue grade, Fisher Scientific, Ltd. Loughborough, UK)
prior to analysis. Retention indices (RIs) were determined
in relation to a series of n-alkanes (C10–C16, Supelco,
Poole, UK) and compounds were identified by comparing
the RIs and mass spectra with published data. Percentage
compositions of detected compounds were calculated by
integrating all peaks in total ion chromatograms.
Radioligand binding profile
A series of concentration-dependent competition binding
assays were performed as described previously[20] using [35S]
t-butylbicyclophosphorothionate (TBPS), [3H] fluni-
trazepam, [3H] MK801 and [3H] nicotine binding assays.
DPPH (2,2-diphenyl-1-picrylhydrazyl) assay
Radical-scavenging capacity was determined according to
the technique reported by,[6] using the EO at concentrations
ranging from 0.0001 to 1 mg/ml. The mixture was shaken
vigorously and allowed to reach a steady-state at room tem-
perature for 30 min. Decolourisation of DPPH was deter-
mined by measuring the absorbance at λ = 517 nm with a
SpectroScan 80D spectrophotometer (Biotech Engineering
Management Co. Ltd. Nicosia – Cyprus). Butylated
hydroxyanisole (BHA) was employed as the positive
control.
Ferrous ion-chelating activity
The ferrous ion-chelating activity of EOs was assessed by
the ferrozine assay as previously described.[21] The reaction
was initiated by adding ferrozine (0.01 M), the mixture
shaken vigorously and left aside at room temperature for
10 min. Absorbance of the solution was then measured
spectrophotometrically at 562 nm. EDTA (0.1%) was used
as a positive control.
CAD cell culture
(Cath.-a-differentiated) cultures were grown at 37°C and in
5% CO2 in 75 cm2 tissue culture flasks (Sarstedt, Newton,
NC, USA) in Dulbecco’s modified eagles’ medium DMEM/
F-12 Media – GlutaMAX-I (GIBCO, Grand Island, NY,
USA), supplemented with 10% fetal bovine serum (FBS;
Sigma, St Louis, MO, USA) Cells were passaged every 6–7
days at a 1:4 dilution.
Treatment of cell cultures with H2O2 and
Aloysia citrodora essential oil
The hydrogen peroxide insult was performed at different
concentrations to determine the dose-dependent effects on
CAD cell survival. A stock solution of H2O2 (2500 μm) in
PBS was freshly prepared. A series of concentrations were
then prepared using Dulbecco’s modified eagles’ medium
DMEM/F-12 Media – GlutaMAX-I supplemented with 10%
FBS to achieve final concentrations of 250, 200, 150, 100
and 50 μm, respectively. Subconfluent cultures (70–80%)
was dislodged by gentle pipetting; transferred and centri-
fuged at 200 × g for 5 min at 4 °C. The pellet was then
resuspended in DMEM/F-12 Media GlutaMAX-I sup-
plemented with 10% FBS. The cell suspension was immedi-
ately plated in 24-well plates and incubated at 37°C and 5%
CO2. After 24 h, the media were replaced with media con-
taining the different H2O2 concentrations prepared earlier
and grown in culture for further 24 h after which an 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide
(MTT) assay was performed. The effect of the EO was ini-
tially investigated by applying different concentrations of
the oil (0.0001, 0.001, 0.01, 0.1 mg/ml) for 24 h to CAD cell
cultures. Viability of neurons was assayed using a standard
MTT assay.
Preconditioning and neuroprotection study
Survival of CAD cells was assessed after 24 h pretreatment
with A. citrodora oil (0.001 and 0.01 mg/ml (w/v)) followed
by 24 h post-treatment with 250 μm H2O2 (i.e. A. citrodora-
containing media removed before addition of H2O2 –
preconditioning protocol). A second set of experiments
were performed when the Aloysia-containing media was not
removed prior to exposure to the H2O2 – neuroprotection
method). N = 12 well replicates from three indepen-
dent cultures were carried out (*P < 0.05; **P < 0.01;
***P < 0.001).
MTT cell viability assay
Phosphate buffered saline (PBS) (136.9 mm 2.68 mm KCl,
4.3 mm Na2HP04, 1.4 mm KH2P04, pH 7.4) containing
5 mg/ml MTT was added to the cultures and incubated at
37°C and in 5% CO2 for 2.5 h. Then MTT-containing
medium was removed, the surface of the wells was rinsed
with PBS before the application of isopropanol. The optical
density of sample was spectrophotometrically read at
595 nm (Thermo Labsystems Multiskan Ascent, V1.3,
Basingstoke, UK).
Treatment of cell cultures with β-Amyloid
Human β-amyloid peptide, Ascent Scientific, UK, was dis-
solved in DMSO (dimethyl sulphoxide) at 1 mg/ml and
stored at −80°C until use. The peptide was then incubated
for 72 h at 37°C, 5% CO2, without agitation. The peptide
was then diluted to the required concentration using
DMEM/F12 plus GlutaMAX +10% Fetal Calf Serum (FCS),
inverted and gently added to neuronal cultures. DMSO in
DMEM/F12 plus GlutaMAX +10% FCS was used as a
control.
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CytoTox 96 nonradioactive assay
CytoTox 96 assay kit (Promega Corporation, Madison, WI,
USA) quantifies LDH (lactate dehydrogenase) levels as a
measure of cell lysis. Media were removed from cells and
centrifuged at 13 000 × g for 2 min. The supernatant con-
taining the LDH was retained and the pellet resuspended in
PBS, using the same volume removed from the cells, and
placed back into the respective well of the 24-well plate. The
plate was then frozen for 2 h at −20°C to lyse all remaining
cells. Cells were subsequently thawed and centrifuged at
13 000 × g for 2 min; again, the supernatant was retained as
a measure of total remaining LDH. Dilutions, 1:10 and 1:20,
were made of each cell culture supernatant using PBS as the
diluent with DMEM/F12 plus 10% FCS used to calibrate
the assay. Equal volumes of substrate mix was added to test
sample and incubated for 30 min at room temperature in
the dark. Reactions were halted with acid stop solutions and
the absorbance measured at 490 nm on a Multiskan Ascent
Plate Reader, version 2.6 (Basingstoke, UK). Cell lysis in the
media supernatant was calculated as a percentage of the
sum of total LDH absorbance, combining the absorbance of
positive control freeze–thawed cells and absorbance of
media containing LDH.
Statistical analysis
Repeated measures ANOVA were performed in triplicate
using GraphPad Prism 5.0 (Graphpad, La Jolla, CA, USA)
program. P values below 0.05 were considered significant
(*P < 0.05; **P < 0.01; ***P < 0.001).
Results
The chemical compositions of the EOs from A. citrodora
collected from Jordan are summarised in Table 1 (in the
order of elution). A total of 63 compounds were identified
representing 93% of the total oil. The major components
for dried and fresh oils included limonene (13.6–20.1%),
geranial (6.3–20.1%), neral (3.7–15.1%), 1,8-cineole (9.2–
9.4%), curcumene (3.5–6.3%), spathulenol (3.1–5.0%) and
caryophyllene oxide (2.2–8.4%), some quantitative vari-
ation in detected terpinoids and phenylpropanoid deriva-
tives was observed between the dried and fresh leaves.
Radioligand binding profile
A series of concentration-dependent (0.0001–0.1 mg/ml)
competition binding assays were performed as described
previously,[20] using [35S] TBPS, [3H] flunitrazepam, [3H]
MK801 and [3H] nicotine binding assays. No effects were
observed for [35S] TBPS, [3H] flunitrazepam, [3H] MK801
binding over the concentration range tested. In contrast,
A. citrodora EO elicited a concentration-dependent inhibi-
tion of [3H] nicotine binding (apparent IC50 = 0.0018 ±
0.0008 mg/ml (n = 3 individual experiments).
Antioxidant activity in cell-free systems
DPPH radical-scavenging activity
DPPH is widely used to test the ability of compounds to act
as free-radical scavengers or hydrogen donors and to evalu-
ate antioxidant activity of plants. EOs of dried and fresh
leaves exhibited a comparable radical-scavenging activity vs
the DPPH radical as 0.1% BHA as reference standard
(Figure 1).
Fe2+ chelating ability
A robust antioxidant capacity was observed with
the A. citrodora EO using the iron-chelating test system.
A. citrodora EOs derived from the fresh leaf displayed a sig-
nificant dose-dependent iron-chelating property (between
0.01–1.0 mg/ml), compared with 0.1% EDTA as positive
control (Figure 2).
Neuroprotective activity of Aloysia
citrodora Palau vs H2O2- induced
neurotoxicity in CAD cells
In the first instance, various concentrations of A. citrodora
EO and H2O2 were assessed for neurotoxic activity. Concen-
trations above 0.1 mg/ml A. citrodora and 100 μm H2O2
elicited a neurotoxic effect (Figures 3–5).
200 μm and 250 μm H2O2 elicited a significant neurotoxic
effect up to 62% loss of cell viability. Pre-exposure to
A. citrodora EO and removal before insult had no effect
upon levels of neurotoxicity with 250 μm H2O2, indicating
that the oil has no preconditioning properties (results not
shown).
In contrast to the preconditioning approach, in the pres-
ence of 0.01 and 0.001 mg/ml A. citrodora EO, 250 μm H2O2
(neuroprotection protocol) failed to elicit a neurotoxic
effect, thus displaying a complete neuroprotection property
at both concentrations.
Neuroprotective activity of A. citrodora oil
vs amyloid-induced neurotoxicity in
CAD cells
CAD cell cultures were subjected to a range of concentra-
tions of synthetic β-amyloid, and cell viability assessed
using an LDH release assay. Clear neurotoxicity was
observed spanning the 2.5–25 μm β-amyloid concentration
range, with up to 70% loss of cell viability (Figure 6a).
A. citrodora (0.01 and 0.001 mg/ml) elicited a significant
dose-dependent neuroprotection from 10 μm β-amyloid
(up to approximately 50%) (Figure 6b).
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Table 1 Percentage composition of the EOs from fresh and dried leaves of Aloysia citrodora grown in Jordan; data obtained from the gas
chromatography-mass spectrometry total ion chromatograms (based on all peaks)
Compound
Fresh leaf oil
percentage composition
Dried leaf oil
percentage composition Experimental RI Published RIa
α-Thujene 0.1 0.1 923 930
α-Pinene 0.6 0.8 929 939
Sabinene 2.0 1.5 966 975
β-Pinene 0.1 0.1 969 979
1-Octen-3-ol 0.4 0.7 976 979
6-Methyl-5-hepten-2-one 1.5 3.4 980 986
Myrcene 0.3 0.3 983 991
Hexenyl acetate 0.1 Nd 1000 (3E)-: 1002
(3Z)-: 1005
2-δ-Carene Tr 0.1 1009 1002
Cymene 0.1 0.3 1018 o-: 1026
p-: 1025
Limonene 13.6 20.1 1025 1029
1,8-Cineole 9.2 9.4 1027 1031
β-Ocimene 1.6 0.1 1041 (Z)-: 1037
(E)-: 1050
Bergamal Nd 0.1 1049 1057
γ-Terpinene 0.1 0.3 1052 1060
cis-Sabinene hydrate 0.7 1.0 1066 1070
Perillene Tr 0.1 1095 1101
Linalool 0.6 0.8 1098 1097
α-Pinene oxide 0.2 0.2 1102 1099
trans-Thujone Nd Tr 1115 1114
trans-p-Mentha-2,8-dien-1-ol 0.2 0.5 1121 1123
α-Campholenal Tr 0.1 1125 1126
cis-Limonene oxide 0.1 0.2 1131 1137
cis-p-Mentha-2,8-dien-1-ol 0.4 0.8 1137 1138
Citronellal 0.2 0.1 1154 1153
Sabina ketone Nd 0.1 1158 1159
Rosefuran epoxide 0.6 0.9 1172 1177
Terpinen-4-ol Tr 0.9 1182 1177
trans-p-Mentha-1(7),8-dien-2-ol 1.6 0.1 1183 1189
α-Terpineol 3.6 3.6 1199 1189
Carveol Tr 0.4 1224 trans-: 1217
cis-: 1229
Nerol 0.6 0.1 1231 1230
Neral 15.1 3.7 1246 1238
Carvone Nd 1.0 1250 1243
Piperitone 0.6 0.3 1259 1253
Geranial 20.1 6.3 1278 1267
Thymol Nd 0.1 1300 1290
Carvacrol Nd 0.6 1308 1299
trans-Carvyl acetate Nd Tr 1340 1342
Piperitenone Nd Tr 1344 1343
α-Cubebene Nd Tr 1351 1351
Eugenol Nd 0.1 1359 1359
α-Copaene 0.3 0.8 1379 1377
Geranyl acetate and β-bourboneneb 1.2 1.6 1385 Geranyl acetate:
1381
β-Bourbonene: 1388
α-Cedrene 0.2 0.6 1417 1412
(E)-Caryophyllene 2.6 2.1 1421 1419
β-Cedrene 0.1 0.3 1424 1421
β-Copaene Tr 0.1 1430 1432
α-Humulene 0.2 0.3 1454 1455
Allo-aromadendrene 0.3 0.8 1458 1460
γ-Muurolene 1.5 0.6 1479 1480
Curcumene 3.5 6.3 1482 γ: 1483
ar: 1481
Bicyclogermacrene 1.9 0.4 1493 1500
Bisabolene Nd 0.1 1506 B-: 1506
(Z)-α-: 1507
β-Curcumene 0.9 Tr 1507 1516
γ-Cadinene 0.2 0.4 1511 1514
δ-Cadinene 0.2 0.4 1514 1523
β-Sesquiphellandrene Tr Tr 1519 1523
trans-Calamenene Nd Tr 1525 1529
Nerolidol 0.5 0.7 1556 (E)-: 1563
(Z)-: 1533
Spathulenol 3.1 5.0 1568 1578
Caryophyllene oxide 2.2 8.4 1571 1583
Tr: < 0.1%; Nd, not detected. Emboldened data accounts for the major components. All compounds identified by comparing experimental retention indices (RI; cal-
culated against an n-alkane series with chromatography performed using a DB-5MS phase), and by comparing mass spectra with published data (Adams, 2001;
NIST, 2008).[22,23].
aPublished Retention Index. bCo-elution.
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Discussion
More than 60 components, comprising of mainly mono-
and sesquiterpenoids were detected in the EOs obtained
from Jordanian A. citrodora dried or fresh leaves (major
components listed in Table 1). Irrespective of whether
derived from dried or fresh leaves, limonene, geranial, neral
and 1,8-cineole were the dominating monoterpenoids. The
qualitative composition of the EOs from fresh and dried
A. citrodora leaves was similar, although some quantitative
differences were observed; notably, the EO from fresh leaves
contained a higher percentage composition of geranial and
neral (isomeric monoterpenoids collectively known as
citral) compared with the EO from dried leaves, whereas
dried leaves EO contained a higher percentage of limonene,
compared with the fresh leaves EO. The monoterpenoids
limonene, geranial, neral and 1,8-cineole have previously
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Figure 1 Antioxidant activity of Aloysia citrodora dried essential
oil using DPPH (2,2-diphenyl-1-picrylhydrazyl) assay. Values are
mean ± Standard Error of the Mean (SEM), n = 3, P < 0.001.
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Figure 3 (a) Treatment of CAD (Cath.-a-differentiated; 24 h) cell cul-
tures with Aloysia citrodora (***P < 0.001 compared with media
control). Concentrations 0.001, 0.01 and 0.05 mg/ml elicited no sig-
nificant neurotoxic effect upon CAD cells. (b) Insult of CAD (24 h) cell
cultures with hydrogen peroxide (***P < 0.001 compared with
control).
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been reported as some of the main constituents of EOs
from A. citrodora (including EOs documented from species
described as synonyms for A. citrodora.[14,24–27] It is essential
to characterise EOs investigated pharmacologically, as oil
composition from a particular species may vary consider-
ably due to various factors, including genetic and environ-
ment influences.[28–34]
The EOs obtained from dried or fresh A. citriodora leaves
shared the terpenic components and were characterised by
high contents of monoterpenes and sesquiterpenes. The
fraction of monoterpene was enriched, mainly due to an
increase in the contribution of limonene with the dried leaf
oil. All other components remained more or less unchanged
both qualitatively and quantitatively. According to the lit-
erature, limonene is the component found to occur in
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highest quantities in EOs of the genus Lippia, followed by
p-cymene, α-pinene, camphor, β-caryophyllene, linalool
and thymol in a decreasing order.[18,19,24–34] In our study,
α-pinene, α-terpinene, sabinene, linalool and caryophyllene
were also identified in low amounts. However, our results
did not show the presence of carvacrol, camphor and
thymol, which have been mentioned in other studies
regarding A. citrodora.[31,35] These monoterpenoids have pre-
viously been reported as some of the main constituents
of EOs from A. citrodora from different parts of the
world.[18,19,24–27] The literature emphasises that a variety of
geographical and ecological factors can lead to qualitative
and quantitative differences in the EO produced. At the
same time, a number of other factors can influence its com-
position, such as the developmental stage of the plant, its
physiology, the age of leaves and growing conditions.
Furthermore, the chemical composition of the EO is also
affected by the isolation procedure and analysis
conditions.[18,19,24–36]
Melissa officinalis is highly valued in herbal medicine and
is native to Europe and Western Asia. A. citrodora is a
common plant in Mediterranean region. Both species have
been described by the same common name (‘Melissa’) and
have been used in traditional herbal medicine as calming
agents, raise attention and help to counter depression with a
good safety profile.[27] However, confusion over plant names
and their identity emphasises why it is essential to authenti-
cate and chemically characterise plants used for medicinal
applications, as performed for the A. citrodora investigated
in this present study. Our studies investigating the composi-
tion of M. officinalis EOs with mechanistic effects relevant
to the CNS report the major components to be carophyllene
(10–26%), geranial (15–31%) neral (10–22%);[23] the latter
two terpinoids are also major components in the
A. citrodora EOs. However, limonene and 1,8-cineole were
not major components of M. officinalis EOs,[23] in contrast
to their high percentage compositions in the A. citrodora
EOs.
Pharmacological targets for the reduction of anxiety,
agitation and aggression include the neurotransmitter
systems, acetylcholine, glutamate and Gamma-
Aminobutyric acid (GABA). In this work, we have charac-
terised the effect of A. citrodora EOs on two major binding
sites of the GABAA receptor (the benzodiazepine site and
the ion channel site) to detect any GABAA receptor modu-
latory activity. To confirm selectivity, interactions with
other common ligand gated ion channel receptors
(NMDA) and neuronal nicotinic receptor were also inves-
tigated. A. citrodora EOs inhibited [3H] nicotine binding in
a concentration-dependent manner with no significant
effects on other major ligand gated ion channels expressed
in the central nervous system. This is in contrast to the
European lemon balm oil, where no significant effect on
[3H] nicotine binding activity was detected (up to 0.1 mg/
ml), but displayed a clear inhibitory effect on [35S] TBPS
binding to the GABAA receptor channel site.[23] Neuronal
nicotinic acetylcholine receptors represent novel targets for
CNS therapeutics and may have substantial roles in medi-
ating antinociception and modulating cognitive perfor-
mance. The oil constituents responsible for this activity
require identification. The potential for developing nAChR
ligands (particularly agonists) for use in AD, Parkinson’s
disease, smoking cessation, anxiety, depression and schizo-
phrenia remains high.
Natural antioxidants that are present in medicinal
herbs are responsible for inhibiting or preventing the del-
eterious consequences of oxidative stress. These antioxi-
dants, which can scavenge free-radicals include many
flavonoids and other phenolic compounds. In the present
study, we have evaluated the free-radical scavenger activity
of A. citrodora EO. The A. citrodora oil exhibited a radical-
scavenging activity at all tested concentrations. This activity
has been reported earlier in several studies for related
plants.[36–39]
Oxidative cellular damage is a multiphase process
involving free-radical chain initiation and propagation
steps. An important mechanism of antioxidative action
is the chelation of transition metals, thus preventing
catalysis of hydrogen peroxide decomposition via
the Fenton-type reaction[31] Therefore, the ability of
A. citrodora EO to chelate iron (II) was investigated. It has
been reported that chelating agents are effective as second-
ary antioxidants because they reduce the redox potential,
thereby stabilising the oxidised form of the metal ion.[40]
As can be seen, the oil derived from fresh leaves was effec-
tively capable of chelating iron (II) and did so in a
concentration-dependent manner to approximately 70% of
the level of the standard chelator, EDTA. The iron (II)
chelating activity of the A. citrodora EO is of significance,
because it has been proposed that the transition metal ions
contributes to the oxidative damage in many neuro-
degenerative disorders and one of the lines of treatments
currently under investigation in the field is selective,
low-affinity binding of transition metals.[40,41] Interestingly,
this property is not shared by the European M. officinalis
EO. This suggests that a comparison of compositions is
worthy in an attempt to identify the neuroactive compo-
nents underlying the pharmacological differences between
the two EOs.
The pharmacological properties displayed by A. citrodora
EO is consistent with a neuroprotective profile. Indeed,
our studies showed, for the first time, that A. citrodora
EO provides complete and partial protection vs H2O2-
and β-amyloid-induced neurotoxicity, respectively, both
relevant to oxidative stress-induced damage in major
neurodegenerative disease.
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Conclusions
In conclusion, the chemical analysis of the EOs from leaves
of A. citrodora cultivated in Jordan showed the presence of
limonene, geranial, neral, 1,8-cineole, curcumene, spathu-
lenol and caryophyllene oxide as the main components.
This study demonstrated for the first time that the
A. citrodora EO possess nicotinic cholinergic, antioxidative
and significant neuroprotective activities, all of which are of
relevance to potential AD therapy, as well as other neuro-
degenerative diseases. We are currently attempting to delin-
eate the neuroactive elements in this oil, using functional
group-based fractionation, responsible for the biological
activity reported herein, and to confirm its utility in vivo.
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